Home > Boards > US OTC > Biotechs > Cytodyn Inc. (CYDY)

I spoke with NP last week. I am

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (3) | Next 10 | Previous | Next
woodenbear Member Profile
 
Followed By 2
Posts 214
Boards Moderated 0
Alias Born 07/25/17
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/20/2019 12:14:59 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 11/20/2019 12:12:39 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 11/20/2019 9:26:56 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/20/2019 9:06:31 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/19/2019 11:35:19 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/12/2019 8:31:48 AM
Amended Small Company Offering and Sale of Securities Without Registration (d/a) Edgar (US Regulatory) - 11/12/2019 7:07:38 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 11/7/2019 9:13:36 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/7/2019 8:36:42 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/31/2019 5:07:01 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/22/2019 8:16:54 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/8/2019 7:10:45 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/8/2019 7:06:29 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/8/2019 7:05:59 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/8/2019 7:04:48 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/8/2019 7:03:53 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 10/8/2019 5:26:49 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 10/3/2019 9:04:31 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/3/2019 8:34:28 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 10/1/2019 6:01:12 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 9/30/2019 4:13:58 PM
Securities Registration Statement (simplified Form) (s-3/a) Edgar (US Regulatory) - 9/27/2019 6:02:58 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 9/19/2019 9:19:37 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/19/2019 8:39:45 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/16/2019 5:14:14 PM
woodenbear   Monday, 10/21/19 11:58:15 AM
Re: None
Post # of 49416 
I spoke with NP last week. I am a long-investor. I supported the company in the To this summer bc I thought based on his public statements that TNBC and deal talks were much further along.

I expressed that while the science and data is undeniable for HIV combo and mono that my concern is that every day a deal is not signed, management’s leverage to get it signed weakens. If I were on the other side of the table in these talks and saw the SP collapsing, I would be tempted to re-negotiate bc CYDY is already ready on thin ice. NP heard my concerns and understood them. He said they have experience difficult negotiations before, but is very confident this deal will close in the time frame he has shared publicly.

He also reiterated the importance of Dr Sacha’s work and that the upcoming publication will finally garner the attention the company deserves. I am also skeptical on this but hopeful. We will see.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (3) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist